skip to main content
Idioma:
Refinado por: Nome da Publicação: Blood remover assunto: Cell Biology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab
Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-term follow-up of the RESONATE phase 3 trial of ibrutinib vs ofatumumab

Byrd, John C. ; Hillmen, Peter ; O'Brien, Susan ; Barrientos, Jacqueline C. ; Reddy, Nishitha M. ; Coutre, Steven ; Tam, Constantine S. ; Mulligan, Stephen P. ; Jaeger, Ulrich ; Barr, Paul M. ; Furman, Richard R. ; Kipps, Thomas J. ; Thornton, Patrick ; Moreno, Carol ; Montillo, Marco ; Pagel, John M. ; Burger, Jan A. ; Woyach, Jennifer A. ; Dai, Sandra ; Vezan, Remus ; James, Danelle F. ; Brown, Jennifer R.

Blood, 2019-05, Vol.133 (19), p.2031-2042 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials
Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials

Spina, Michele ; Jaeger, Ulrich ; Sparano, Joseph A. ; Talamini, Renato ; Simonelli, Cecilia ; Michieli, Mariagrazia ; Rossi, Giuseppe ; Nigra, Ezio ; Berretta, Massimiliano ; Cattaneo, Chiara ; Rieger, Armin C. ; Vaccher, Emanuela ; Tirelli, Umberto

Blood, 2005-03, Vol.105 (5), p.1891-1897 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Autologous peripheral blood stem cell transplantation for acute myeloid leukemia
Autologous peripheral blood stem cell transplantation for acute myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Autologous peripheral blood stem cell transplantation for acute myeloid leukemia

Vellenga, Edo ; van Putten, Wim ; Ossenkoppele, Gert J. ; Verdonck, Leo F. ; Theobald, Matthias ; Cornelissen, Jan J. ; Huijgens, Peter C. ; Maertens, Johan ; Gratwohl, Alois ; Schaafsma, Ron ; Schanz, Urs ; Graux, Carlos ; Schouten, Harry C. ; Ferrant, Augustin ; Bargetzi, Mario ; Fey, Martin F. ; Löwenberg, Bob

Blood, 2011-12, Vol.118 (23), p.6037-6042 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
4
Updated Efficacy Including Genetic and Clinical Subgroup Analysis and Overall Safety in the Phase 3 RESONATETM Trial of Ibrutinib Versus Ofatumumab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Updated Efficacy Including Genetic and Clinical Subgroup Analysis and Overall Safety in the Phase 3 RESONATETM Trial of Ibrutinib Versus Ofatumumab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Updated Efficacy Including Genetic and Clinical Subgroup Analysis and Overall Safety in the Phase 3 RESONATETM Trial of Ibrutinib Versus Ofatumumab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Brown, Jennifer R. ; Hillmen, Peter ; O’Brien, Susan ; Barrientos, Jaqueline C. ; Reddy, Nishitha ; Coutre, Steven ; Tam, Constantine ; Mulligan, Stephen ; Jaeger, Ulrich ; Barr, Paul M. ; Furman, Richard R. ; Kipps, Thomas J. ; Cymbalista, Florence ; Thornton, Patrick ; Caligaris-Cappio, Federico ; Delgado, Julio ; Montillo, Marco ; DeVos, Sven ; Moreno, Carol ; Pagel, John ; Burger, Jan A. ; Chung, Devon ; Lin, Jennifer ; Gau, Linda ; Chang, Betty ; McGreivy, Jesse ; James, Danelle F. ; Byrd, John C.

Blood, 2014-12, Vol.124 (21), p.3331-3331 [Periódico revisado por pares]

Elsevier Inc

Texto completo disponível

Citações Citado por
5
Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study
Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Gemtuzumab ozogamicin as postremission treatment in AML at 60 years of age or more: results of a multicenter phase 3 study

Löwenberg, Bob ; Beck, Joachim ; Graux, Carlos ; van Putten, Wim ; Schouten, Harry C. ; Verdonck, Leo F. ; Ferrant, Augustin ; Sonneveld, Pieter ; Jongen-Lavrencic, Mojca ; von Lilienfeld-Toal, Marie ; Biemond, Bart J. ; Vellenga, Edo ; Breems, Dimitri ; de Muijnck, Hilde ; Schaafsma, Ron ; Verhoef, Gregor ; Döhner, Hartmut ; Gratwohl, Alois ; Pabst, Thomas ; Ossenkoppele, Gert J. ; Maertens, Johan ; for the Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON) ; German Austrian AML Study Group (AMLSG) ; Swiss Group for Clinical Cancer Research Collaborative Group (SAKK)

Blood, 2010-04, Vol.115 (13), p.2586-2591 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.